| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -120 @ USD 105.88 | USD -12,706 | The ETF sold 120 shares of DVA on 2026-01-28. The shares were previously bought for an average price of USD 137.61. The DaVita HealthCare Partners Inc shares were sold for -23.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,808 The average price that the ETF previously sold DVA share for is USD 141.739 which is higher than the selling price of USD 105.88 on 2026-01-28. |
| HSIC - Henry Schein Inc | SELL | -348 @ USD 75.08 | USD -26,128 | The ETF sold 348 shares of HSIC on 2026-01-28. The shares were previously bought for an average price of USD 71.7795. The Henry Schein Inc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 1,149 The average price that the ETF previously sold HSIC share for is USD 69.9688 so the ETF has sold 348 shares on 2026-01-28 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -168 @ USD 187 | USD -31,416 | The ETF sold 168 shares of MOH on 2026-01-28. The shares were previously bought for an average price of USD 227.448. The MOH shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,795 The average price that the ETF previously sold MOH share for is USD 264.981 which is higher than the selling price of USD 187 on 2026-01-28. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -168 @ USD 187 | USD -31,416 | The ETF sold 168 shares of MOH on 2026-01-28. The shares were previously bought for an average price of USD 227.448. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,795 The average price that the ETF previously sold MOH share for is USD 264.981 which is higher than the selling price of USD 187 on 2026-01-28. |
| BAX - Baxter International Inc | SELL | -1,722 @ USD 19.61 | USD -33,768 | The ETF sold 1722 shares of BAX on 2026-01-28. The shares were previously bought for an average price of USD 26.4445. The Baxter International Inc shares were sold for -25.8% lower than average price of previous purchases. This resulted in an overall loss of USD 11,769 The average price that the ETF previously sold BAX share for is USD 29.7696 which is higher than the selling price of USD 19.61 on 2026-01-28. |
| TECH - Bio-Techne Corp | SELL | -522 @ USD 65.56 | USD -34,222 | The ETF sold 522 shares of TECH on 2026-01-28. The shares were previously bought for an average price of USD 60.9177. The Bio-Techne Corp shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of USD 2,423 The average price that the ETF previously sold TECH share for is USD 65.8174 which is higher than the selling price of USD 65.56 on 2026-01-28. |
| CRL - Creightons Plc | SELL | -162 @ USD 216.88 | USD -35,135 | The ETF sold 162 shares of CRL on 2026-01-28. The shares were previously bought for an average price of USD 172.389. The Creightons Plc shares were sold for 25.8% higher than average price of previous purchases. This sale made a profit of USD 7,208 The average price that the ETF previously sold CRL share for is USD 176.42 so the ETF has sold 162 shares on 2026-01-28 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -180 @ USD 203.02 | USD -36,544 | The ETF sold 180 shares of UHS on 2026-01-28. The shares were previously bought for an average price of USD 198.304. The Universal Health Services Inc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 849 The average price that the ETF previously sold UHS share for is USD 198.256 so the ETF has sold 180 shares on 2026-01-28 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -222 @ USD 164.92 | USD -36,612 | The ETF sold 222 shares of ALGN on 2026-01-28. The shares were previously bought for an average price of USD 166.692. The Align Technology Inc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 393 The average price that the ETF previously sold ALGN share for is USD 197.186 which is higher than the selling price of USD 164.92 on 2026-01-28. |
| SOLV - Solventum Corp. | SELL | -492 @ USD 76.6 | USD -37,687 | The ETF sold 492 shares of SOLV on 2026-01-28. The shares were previously bought for an average price of USD 74.5707. The Solventum Corp. shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 998 The average price that the ETF previously sold SOLV share for is USD 72.5762 so the ETF has sold 492 shares on 2026-01-28 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -378 @ USD 111.13 | USD -42,007 | The ETF sold 378 shares of RVTY on 2026-01-28. The shares were previously bought for an average price of USD 103.08. The Revvity Inc. shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 3,043 The average price that the ETF previously sold RVTY share for is USD 106.501 so the ETF has sold 378 shares on 2026-01-28 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -3,870 @ USD 12.97 | USD -50,194 | The ETF sold 3870 shares of VTRS on 2026-01-28. The shares were previously bought for an average price of USD 10.5883. The Viatris Inc shares were sold for 22.5% higher than average price of previous purchases. This sale made a profit of USD 9,217 The average price that the ETF previously sold VTRS share for is USD 11.194 so the ETF has sold 3870 shares on 2026-01-28 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -264 @ USD 194.01 | USD -51,219 | The ETF sold 264 shares of HUM on 2026-01-28. The shares were previously bought for an average price of USD 265.687. The Hummingbird Resources PLC shares were sold for -27.0% lower than average price of previous purchases. This resulted in an overall loss of USD 18,923 The average price that the ETF previously sold HUM share for is USD 267.402 which is higher than the selling price of USD 194.01 on 2026-01-28. |
| HUM - Humana Inc | SELL | -264 @ USD 194.01 | USD -51,219 | The ETF sold 264 shares of HUM on 2026-01-28. The shares were previously bought for an average price of USD 265.687. The Humana Inc shares were sold for -27.0% lower than average price of previous purchases. This resulted in an overall loss of USD 18,923 The average price that the ETF previously sold HUM share for is USD 267.402 which is higher than the selling price of USD 194.01 on 2026-01-28. |
| MRNA - Moderna Inc | SELL | -1,152 @ USD 45.3 | USD -52,186 | The ETF sold 1152 shares of MRNA on 2026-01-28. The shares were previously bought for an average price of USD 30.8284. The Moderna Inc shares were sold for 46.9% higher than average price of previous purchases. This sale made a profit of USD 16,671 The average price that the ETF previously sold MRNA share for is USD 37.0243 so the ETF has sold 1152 shares on 2026-01-28 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -672 @ USD 80.48 | USD -54,083 | The ETF sold 672 shares of COO on 2026-01-28. The shares were previously bought for an average price of USD 80.8553. The The Cooper Companies, Inc. Common Stock shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 252 The average price that the ETF previously sold COO share for is USD 88.24 which is higher than the selling price of USD 80.48 on 2026-01-28. |
| INCY - Incyte Corporation | SELL | -552 @ USD 101.18 | USD -55,851 | The ETF sold 552 shares of INCY on 2026-01-28. The shares were previously bought for an average price of USD 82.6499. The Incyte Corporation shares were sold for 22.4% higher than average price of previous purchases. This sale made a profit of USD 10,229 The average price that the ETF previously sold INCY share for is USD 76.8012 so the ETF has sold 552 shares on 2026-01-28 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -744 @ USD 75.1 | USD -55,874 | The ETF sold 744 shares of HOLX on 2026-01-28. The shares were previously bought for an average price of USD 69.324. The Hologic Inc shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 4,297 The average price that the ETF previously sold HOLX share for is USD 71.1553 so the ETF has sold 744 shares on 2026-01-28 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -240 @ USD 235.89 | USD -56,614 | The ETF sold 240 shares of WST on 2026-01-28. The shares were previously bought for an average price of USD 259.743. The West Pharmaceutical Services Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,725 The average price that the ETF previously sold WST share for is USD 284.477 which is higher than the selling price of USD 235.89 on 2026-01-28. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -666 @ USD 85.71 | USD -57,083 | The ETF sold 666 shares of ZBH on 2026-01-28. The shares were previously bought for an average price of USD 100.17. The Zimmer Biomet Holdings Inc shares were sold for -14.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,630 The average price that the ETF previously sold ZBH share for is USD 102.893 which is higher than the selling price of USD 85.71 on 2026-01-28. |
| PODD - Insulet Corporation | SELL | -234 @ USD 258.2 | USD -60,419 | The ETF sold 234 shares of PODD on 2026-01-28. The shares were previously bought for an average price of USD 294.798. The Insulet Corporation shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,564 The average price that the ETF previously sold PODD share for is USD 277.822 which is higher than the selling price of USD 258.2 on 2026-01-28. |
| CNC - Concurrent Technologies Plc | SELL | -1,566 @ USD 41.9 | USD -65,615 | The ETF sold 1566 shares of CNC on 2026-01-28. The shares were previously bought for an average price of USD 46.156. The Concurrent Technologies Plc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 6,665 The average price that the ETF previously sold CNC share for is USD 52.1695 which is higher than the selling price of USD 41.9 on 2026-01-28. |
| DGX - Quest Diagnostics Incorporated | SELL | -378 @ USD 182.74 | USD -69,076 | The ETF sold 378 shares of DGX on 2026-01-28. The shares were previously bought for an average price of USD 176.136. The Quest Diagnostics Incorporated shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 2,496 The average price that the ETF previously sold DGX share for is USD 166.568 so the ETF has sold 378 shares on 2026-01-28 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -276 @ USD 268.04 | USD -73,979 | The ETF sold 276 shares of LH on 2026-01-28. The shares were previously bought for an average price of USD 257.716. The Laboratory Corporation of America Holdings shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 2,849 The average price that the ETF previously sold LH share for is USD 244.412 so the ETF has sold 276 shares on 2026-01-28 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -198 @ USD 385.03 | USD -76,236 | The ETF sold 198 shares of WAT on 2026-01-28. The shares were previously bought for an average price of USD 356.357. The Waters Corporation shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 5,677 The average price that the ETF previously sold WAT share for is USD 366.465 so the ETF has sold 198 shares on 2026-01-28 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -198 @ USD 385.03 | USD -76,236 | The ETF sold 198 shares of WAT on 2026-01-28. The shares were previously bought for an average price of USD 356.357. The MULETFWATIMETFP shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 5,677 The average price that the ETF previously sold WAT share for is USD 366.465 so the ETF has sold 198 shares on 2026-01-28 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -486 @ USD 174.83 | USD -84,967 | The ETF sold 486 shares of BIIB on 2026-01-28. The shares were previously bought for an average price of USD 150.019. The Biogen Inc shares were sold for 16.5% higher than average price of previous purchases. This sale made a profit of USD 12,058 The average price that the ETF previously sold BIIB share for is USD 154.281 so the ETF has sold 486 shares on 2026-01-28 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -330 @ USD 260.86 | USD -86,084 | The ETF sold 330 shares of STE on 2026-01-28. The shares were previously bought for an average price of USD 239.8. The STERIS plc shares were sold for 8.8% higher than average price of previous purchases. This sale made a profit of USD 6,950 The average price that the ETF previously sold STE share for is USD 226.15 so the ETF has sold 330 shares on 2026-01-28 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -66 @ USD 1401.64 | USD -92,508 | The ETF sold 66 shares of MTD on 2026-01-28. The shares were previously bought for an average price of USD 1313.44. The Mettler-Toledo International Inc shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 5,821 The average price that the ETF previously sold MTD share for is USD 1261.71 so the ETF has sold 66 shares on 2026-01-28 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -66 @ USD 1401.64 | USD -92,508 | The ETF sold 66 shares of MTD on 2026-01-28. The shares were previously bought for an average price of USD 1313.44. The AMUNDI EUR GOV 710 shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 5,821 The average price that the ETF previously sold MTD share for is USD 1261.71 so the ETF has sold 66 shares on 2026-01-28 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,308 @ USD 73.36 | USD -95,955 | The ETF sold 1308 shares of DXCM on 2026-01-28. The shares were previously bought for an average price of USD 73.5715. The DexCom Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 277 The average price that the ETF previously sold DXCM share for is USD 75.7918 which is higher than the selling price of USD 73.36 on 2026-01-28. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,512 @ USD 79.26 | USD -119,841 | The ETF sold 1512 shares of GEHC on 2026-01-28. The shares were previously bought for an average price of USD 79.6943. The GE HealthCare Technologies Inc. shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 657 The average price that the ETF previously sold GEHC share for is USD 79.4124 which is higher than the selling price of USD 79.26 on 2026-01-28. |
| RMD - ResMed Inc | SELL | -486 @ USD 257.72 | USD -125,252 | The ETF sold 486 shares of RMD on 2026-01-28. The shares were previously bought for an average price of USD 251.704. The ResMed Inc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 2,924 The average price that the ETF previously sold RMD share for is USD 245.241 so the ETF has sold 486 shares on 2026-01-28 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -942 @ USD 133.87 | USD -126,106 | The ETF sold 942 shares of A on 2026-01-28. The shares were previously bought for an average price of USD 132.038. The Agilent Technologies Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 1,726 The average price that the ETF previously sold A share for is USD 132.246 so the ETF has sold 942 shares on 2026-01-28 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -570 @ USD 239.76 | USD -136,663 | The ETF sold 570 shares of IQV on 2026-01-28. The shares were previously bought for an average price of USD 199.781. The IQVIA Holdings Inc shares were sold for 20.0% higher than average price of previous purchases. This sale made a profit of USD 22,788 The average price that the ETF previously sold IQV share for is USD 193.4 so the ETF has sold 570 shares on 2026-01-28 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,932 @ USD 81.86 | USD -158,154 | The ETF sold 1932 shares of EW on 2026-01-28. The shares were previously bought for an average price of USD 76.5421. The Edwards Lifesciences Corp shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 10,274 The average price that the ETF previously sold EW share for is USD 73.6862 so the ETF has sold 1932 shares on 2026-01-28 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -786 @ USD 210.39 | USD -165,367 | The ETF sold 786 shares of CAH on 2026-01-28. The shares were previously bought for an average price of USD 158.744. The Cardinal Health Inc shares were sold for 32.5% higher than average price of previous purchases. This sale made a profit of USD 40,594 The average price that the ETF previously sold CAH share for is USD 142.544 so the ETF has sold 786 shares on 2026-01-28 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -1,470 @ USD 121.93 | USD -179,237 | The ETF sold 1470 shares of ZTS on 2026-01-28. The shares were previously bought for an average price of USD 148.669. The Zoetis Inc shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 39,306 The average price that the ETF previously sold ZTS share for is USD 161.885 which is higher than the selling price of USD 121.93 on 2026-01-28. |
| IDXX - IDEXX Laboratories Inc | SELL | -264 @ USD 687.74 | USD -181,563 | The ETF sold 264 shares of IDXX on 2026-01-28. The shares were previously bought for an average price of USD 583.509. The IDEXX Laboratories Inc shares were sold for 17.9% higher than average price of previous purchases. This sale made a profit of USD 27,517 The average price that the ETF previously sold IDXX share for is USD 494.403 so the ETF has sold 264 shares on 2026-01-28 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -954 @ USD 201.92 | USD -192,632 | The ETF sold 954 shares of BDX on 2026-01-28. The shares were previously bought for an average price of USD 204.385. The Becton Dickinson and Company shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,352 The average price that the ETF previously sold BDX share for is USD 208.781 which is higher than the selling price of USD 201.92 on 2026-01-28. |
| COR - Cencora Inc. | SELL | -642 @ USD 350.54 | USD -225,047 | The ETF sold 642 shares of COR on 2026-01-28. The shares were previously bought for an average price of USD 305.622. The Cencora Inc. shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of USD 28,837 The average price that the ETF previously sold COR share for is USD 274.24 so the ETF has sold 642 shares on 2026-01-28 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -888 @ USD 272.38 | USD -241,873 | The ETF sold 888 shares of CI on 2026-01-28. The shares were previously bought for an average price of USD 295.771. The Cigna Corp shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 20,771 The average price that the ETF previously sold CI share for is USD 306.672 which is higher than the selling price of USD 272.38 on 2026-01-28. |
| ELV - Elevance Health Inc | SELL | -738 @ USD 341.85 | USD -252,285 | The ETF sold 738 shares of ELV on 2026-01-28. The shares were previously bought for an average price of USD 365.201. The Elevance Health Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 17,233 The average price that the ETF previously sold ELV share for is USD 383.74 which is higher than the selling price of USD 341.85 on 2026-01-28. |
| ELV - Elevance Health Inc | SELL | -738 @ USD 341.85 | USD -252,285 | The ETF sold 738 shares of ELV on 2026-01-28. The shares were previously bought for an average price of USD 365.201. The Elevance Health Inc shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 17,233 The average price that the ETF previously sold ELV share for is USD 383.74 which is higher than the selling price of USD 341.85 on 2026-01-28. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -336 @ USD 751.13 | USD -252,380 | The ETF sold 336 shares of REGN on 2026-01-28. The shares were previously bought for an average price of USD 669.517. The Regeneron Pharmaceuticals Inc shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 27,422 The average price that the ETF previously sold REGN share for is USD 693.772 so the ETF has sold 336 shares on 2026-01-28 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -528 @ USD 491.23 | USD -259,369 | The ETF sold 528 shares of HCA on 2026-01-28. The shares were previously bought for an average price of USD 399.497. The HCA Holdings Inc shares were sold for 23.0% higher than average price of previous purchases. This sale made a profit of USD 48,435 The average price that the ETF previously sold HCA share for is USD 370.014 so the ETF has sold 528 shares on 2026-01-28 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -4,218 @ USD 74.03 | USD -312,259 | The ETF sold 4218 shares of CVS on 2026-01-28. The shares were previously bought for an average price of USD 70.8883. The CVS Health Corp shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 13,252 The average price that the ETF previously sold CVS share for is USD 61.2162 so the ETF has sold 4218 shares on 2026-01-28 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -408 @ USD 826.62 | USD -337,261 | The ETF sold 408 shares of MCK on 2026-01-28. The shares were previously bought for an average price of USD 721.001. The McKesson Corporation shares were sold for 14.6% higher than average price of previous purchases. This sale made a profit of USD 43,093 The average price that the ETF previously sold MCK share for is USD 660.017 so the ETF has sold 408 shares on 2026-01-28 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,762 @ USD 54.62 | USD -369,340 | The ETF sold 6762 shares of BMY on 2026-01-28. The shares were previously bought for an average price of USD 52.1026. The Bloomsbury Publishing Plc shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 17,023 The average price that the ETF previously sold BMY share for is USD 53.5114 so the ETF has sold 6762 shares on 2026-01-28 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -840 @ USD 477.91 | USD -401,444 | The ETF sold 840 shares of VRTX on 2026-01-28. The shares were previously bought for an average price of USD 443.684. The Vertex Pharmaceuticals Inc shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 28,750 The average price that the ETF previously sold VRTX share for is USD 457.212 so the ETF has sold 840 shares on 2026-01-28 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,140 @ USD 357.83 | USD -407,926 | The ETF sold 1140 shares of SYK on 2026-01-28. The shares were previously bought for an average price of USD 372.362. The Stryker Corporation shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 16,566 The average price that the ETF previously sold SYK share for is USD 375.751 which is higher than the selling price of USD 357.83 on 2026-01-28. |
| MDT - Medtronic PLC | SELL | -4,254 @ USD 100.79 | USD -428,761 | The ETF sold 4254 shares of MDT on 2026-01-28. The shares were previously bought for an average price of USD 92.805. The Medtronic PLC shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of USD 33,968 The average price that the ETF previously sold MDT share for is USD 87.977 so the ETF has sold 4254 shares on 2026-01-28 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -4,920 @ USD 93.79 | USD -461,447 | The ETF sold 4920 shares of BSX on 2026-01-28. The shares were previously bought for an average price of USD 98.7305. The Boston Scientific Corporation shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 24,307 The average price that the ETF previously sold BSX share for is USD 94.286 which is higher than the selling price of USD 93.79 on 2026-01-28. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,920 @ USD 93.79 | USD -461,447 | The ETF sold 4920 shares of BSX on 2026-01-28. The shares were previously bought for an average price of USD 98.7305. The MULSTRXSSXIMETFP shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 24,307 The average price that the ETF previously sold BSX share for is USD 94.286 which is higher than the selling price of USD 93.79 on 2026-01-28. |
| DHR - Danaher Corporation | SELL | -2,082 @ USD 224.54 | USD -467,492 | The ETF sold 2082 shares of DHR on 2026-01-28. The shares were previously bought for an average price of USD 216.094. The Danaher Corporation shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 17,585 The average price that the ETF previously sold DHR share for is USD 224.005 so the ETF has sold 2082 shares on 2026-01-28 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -2,082 @ USD 224.54 | USD -467,492 | The ETF sold 2082 shares of DHR on 2026-01-28. The shares were previously bought for an average price of USD 216.094. The Danaher Corporation shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 17,585 The average price that the ETF previously sold DHR share for is USD 224.005 so the ETF has sold 2082 shares on 2026-01-28 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -18,864 @ USD 25.86 | USD -487,823 | The ETF sold 18864 shares of PFE on 2026-01-28. The shares were previously bought for an average price of USD 25.3944. The Pfizer Inc shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 8,783 The average price that the ETF previously sold PFE share for is USD 25.5336 so the ETF has sold 18864 shares on 2026-01-28 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -4,116 @ USD 139.72 | USD -575,088 | The ETF sold 4116 shares of GILD on 2026-01-28. The shares were previously bought for an average price of USD 113.161. The Guild Esports Plc shares were sold for 23.5% higher than average price of previous purchases. This sale made a profit of USD 109,317 The average price that the ETF previously sold GILD share for is USD 102.159 so the ETF has sold 4116 shares on 2026-01-28 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,782 @ USD 342.22 | USD -609,836 | The ETF sold 1782 shares of AMGN on 2026-01-28. The shares were previously bought for an average price of USD 307.049. The Amgen Inc shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 62,675 The average price that the ETF previously sold AMGN share for is USD 294.569 so the ETF has sold 1782 shares on 2026-01-28 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -5,766 @ USD 106.05 | USD -611,484 | The ETF sold 5766 shares of ABT on 2026-01-28. The shares were previously bought for an average price of USD 128.059. The Abbott Laboratories shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 126,904 The average price that the ETF previously sold ABT share for is USD 122.245 which is higher than the selling price of USD 106.05 on 2026-01-28. |
| ISRG - Intuitive Surgical Inc | SELL | -1,176 @ USD 522.04 | USD -613,919 | The ETF sold 1176 shares of ISRG on 2026-01-28. The shares were previously bought for an average price of USD 523.406. The Intuitive Surgical Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,606 The average price that the ETF previously sold ISRG share for is USD 532.703 which is higher than the selling price of USD 522.04 on 2026-01-28. |
| TMO - Time Out Group plc | SELL | -1,242 @ USD 608.02 | USD -755,161 | The ETF sold 1242 shares of TMO on 2026-01-28. The shares were previously bought for an average price of USD 528.675. The Time Out Group plc shares were sold for 15.0% higher than average price of previous purchases. This sale made a profit of USD 98,546 The average price that the ETF previously sold TMO share for is USD 509.91 so the ETF has sold 1242 shares on 2026-01-28 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -8,238 @ USD 106.9 | USD -880,642 | The ETF sold 8238 shares of MRK on 2026-01-28. The shares were previously bought for an average price of USD 91.5836. The Marks Electrical Group PLC shares were sold for 16.7% higher than average price of previous purchases. This sale made a profit of USD 126,177 The average price that the ETF previously sold MRK share for is USD 94.8768 so the ETF has sold 8238 shares on 2026-01-28 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -8,238 @ USD 106.9 | USD -880,642 | The ETF sold 8238 shares of MRK on 2026-01-28. The shares were previously bought for an average price of USD 91.5836. The Merck & Company Inc shares were sold for 16.7% higher than average price of previous purchases. This sale made a profit of USD 126,177 The average price that the ETF previously sold MRK share for is USD 94.8768 so the ETF has sold 8238 shares on 2026-01-28 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,000 @ USD 294.02 | USD -882,060 | The ETF sold 3000 shares of UNH on 2026-01-28. The shares were previously bought for an average price of USD 399.656. The UnitedHealth Group Incorporated shares were sold for -26.4% lower than average price of previous purchases. This resulted in an overall loss of USD 316,908 The average price that the ETF previously sold UNH share for is USD 468.515 which is higher than the selling price of USD 294.02 on 2026-01-28. |
| ABBV - AbbVie Inc | SELL | -5,856 @ USD 218.67 | USD -1,280,532 | The ETF sold 5856 shares of ABBV on 2026-01-28. The shares were previously bought for an average price of USD 208.536. The AbbVie Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 59,345 The average price that the ETF previously sold ABBV share for is USD 192.777 so the ETF has sold 5856 shares on 2026-01-28 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -7,980 @ USD 227.72 | USD -1,817,206 | The ETF sold 7980 shares of JNJ on 2026-01-28. The shares were previously bought for an average price of USD 178.679. The Johnson & Johnson shares were sold for 27.4% higher than average price of previous purchases. This sale made a profit of USD 391,347 The average price that the ETF previously sold JNJ share for is USD 161.752 so the ETF has sold 7980 shares on 2026-01-28 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -2,628 @ USD 1023.8 | USD -2,690,546 | The ETF sold 2628 shares of LLY on 2026-01-28. The shares were previously bought for an average price of USD 867.994. The Eli Lilly and Company shares were sold for 18.0% higher than average price of previous purchases. This sale made a profit of USD 409,458 The average price that the ETF previously sold LLY share for is USD 824.942 so the ETF has sold 2628 shares on 2026-01-28 at a higher price than the previous selling average. |